← Leaderboards
William Weihao Tang
University Of Utah
$252,288
Attributed
$252,288
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $57.5K · FY2021–25$100K$75K$50K$25K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$252,288 · 1
By mechanism
F30$252,288 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Martha Or Marty L Slattery$38,713,014
- A Gordon Smith$10,319,540
- Carl S. Thummel$15,049,537
- Jared P Rutter$13,915,631
- Alphonsus Ng$2,758,753
Others in their field
Other Emerging Leaders on “Environment”
- Valerie Koch · University Corporation For Atmospheric Res$244,517,972
- Scott Topper · Broad Institute, Inc.$77,958,806
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,503,514
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Prasant Mohapatra · University Of California At Davis$40,097,014
Research focus
EnvironmentExclusionAnti-Pd1 TherapyEffective TherapyAnti-Tumor Immune ResponseCd8-Positive T-LymphocytesCell CompartmentationCell DeathCd3 AntigensAdaptive Immune ResponseCellular BiologyCd8b1 GeneColonColon AdenocarcinomaColon Cancer PatientsColon CarcinomaColonic NeoplasmsColorectal CancerCell GrowthCytotoxic T-LymphocytesCellsData SetDeath RateFibrosis
Grant awards (5)
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1$57,538
F30 · FY2025 · CA · contact PI
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1$56,974
F30 · FY2024 · CA · contact PI
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1$46,792
F30 · FY2023 · CA · contact PI
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1$45,850
F30 · FY2022 · CA · contact PI
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1$45,134
F30 · FY2021 · CA · contact PI